Tech Company Financing Transactions
NeurogesX Funding Round
On 3/31/2007, NeurogesX raised $3.3 million in funding from Arch Venture Partners and Montreux Equity Partners.
Transaction Overview
Company Name
Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$3,330,000
Round
Undisclosed
Investors
Arch Venture Partners (Robert Nelsen)
Montreux Equity Partners (Daniel Turner)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
999 Baker Way 200
San Mateo, CA 94404
USA
San Mateo, CA 94404
USA
Phone
Website
Email Address
Overview
NeurogesX is a privately held specialty pharmaceutical company focusing on the development novel treatments for improved relief of neuropathic pain and improved quality of life for neuropathic pain patients using advanced neuroscience insights and innovative delivery technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronald Martell
Chief Financial Officer
Stephen Ghiglieri
Chief Medical Officer
Stephen Peroutka
Browse more venture capital transactions:
Prev: 3/31/2007: Cogency Software venture capital transaction
Next: 4/1/2007: nLight venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs